Tofacitinib for refractory ocular mucous membrane pemphigoid
Purpose: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). Observations: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies. Treatment with tofacitinib led to durable control of conjunct...
Main Authors: | Hayley James, Grace L. Paley, Richard Brasington, Philip L. Custer, Todd P. Margolis, Michael A. Paley |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993621001134 |
Similar Items
-
A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry
by: Janet Lee, et al.
Published: (2019-09-01) -
The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature
by: Soheil Tavakolpour
Published: (2016-01-01) -
An elderly Hispanic male with mucosal erosions
by: Juan D. Dufflart Ocampo, et al.
Published: (2023-12-01) -
Tracheotomy avoided in laryngeal mucous membrane pemphigoid treated with rituximab
by: Daniela A. Brake, et al.
Published: (2020-06-01) -
Successful treatment of recalcitrant mucous membrane pemphigoid with multisystem involvement with baricitinib and methotrexate
by: Kevin M. Burningham, MD, et al.
Published: (2022-09-01)